Both in Pharmaceuticals
Imunon vs Skye Bioscience
Over the past year IMNN returned −81.4% and SKYE returned −88.7%; their daily moves had a correlation of 0.12.
IMNN −81.4% SKYE −88.7%Growth of $1, one year, split-adjusted
| Metric | IMNN | SKYE |
|---|---|---|
| Price | $0.8762 | $1.45 |
| Market cap | $4.9M | $6.4M |
| Today | −28.76% | −7.64% |
| 1 month | −36.5% | −9.9% |
| 6 months | −68.1% | −80.5% |
| Year to date | −77.0% | −75.8% |
| 1 year | −81.9% | −88.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$169.7K | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 92.0% | 616.9% |
| Short % of float | 1.2% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).